Anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review

Psychiatric disorders commonly co-exist with the diagnosis of chronic kidney disease (CKD). Research on depression and CKD has increased to a great extent. Multiple studies have demonstrated that depression is more prevalent in CKD and that end-stage renal disease is a robust risk factor for adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Goh, Zhong Sheng, Griva, Konstadina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856029/
https://www.ncbi.nlm.nih.gov/pubmed/29559806
http://dx.doi.org/10.2147/IJNRD.S126615
_version_ 1783307234277588992
author Goh, Zhong Sheng
Griva, Konstadina
author_facet Goh, Zhong Sheng
Griva, Konstadina
author_sort Goh, Zhong Sheng
collection PubMed
description Psychiatric disorders commonly co-exist with the diagnosis of chronic kidney disease (CKD). Research on depression and CKD has increased to a great extent. Multiple studies have demonstrated that depression is more prevalent in CKD and that end-stage renal disease is a robust risk factor for adverse outcomes such as hospitalization and mortality, yet these are often underdiagnosed or untreated. This review provides a selective overview on the prevalence rates of depression and anxiety in patients with CKD and across renal replacement therapies, the factors most consistently associated with symptoms of distress and their clinical implications. Finally, treatment and management strategies from relevant literature are appraised and discussed.
format Online
Article
Text
id pubmed-5856029
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58560292018-03-20 Anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review Goh, Zhong Sheng Griva, Konstadina Int J Nephrol Renovasc Dis Review Psychiatric disorders commonly co-exist with the diagnosis of chronic kidney disease (CKD). Research on depression and CKD has increased to a great extent. Multiple studies have demonstrated that depression is more prevalent in CKD and that end-stage renal disease is a robust risk factor for adverse outcomes such as hospitalization and mortality, yet these are often underdiagnosed or untreated. This review provides a selective overview on the prevalence rates of depression and anxiety in patients with CKD and across renal replacement therapies, the factors most consistently associated with symptoms of distress and their clinical implications. Finally, treatment and management strategies from relevant literature are appraised and discussed. Dove Medical Press 2018-03-12 /pmc/articles/PMC5856029/ /pubmed/29559806 http://dx.doi.org/10.2147/IJNRD.S126615 Text en © 2018 Goh and Griva. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Goh, Zhong Sheng
Griva, Konstadina
Anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review
title Anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review
title_full Anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review
title_fullStr Anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review
title_full_unstemmed Anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review
title_short Anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review
title_sort anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856029/
https://www.ncbi.nlm.nih.gov/pubmed/29559806
http://dx.doi.org/10.2147/IJNRD.S126615
work_keys_str_mv AT gohzhongsheng anxietyanddepressioninpatientswithendstagerenaldiseaseimpactandmanagementchallengesanarrativereview
AT grivakonstadina anxietyanddepressioninpatientswithendstagerenaldiseaseimpactandmanagementchallengesanarrativereview